Note: You clicked on an external link, which has been disabled in order to keep your shopping session open.
Western blot analysis of Phospho-IR/IGF1R pTyr1162/1163 in CHO cells transfected with Insulin-stimulated IR (lanes 2,4,6) or unstimulated cells (lanes 1,3,5) using a Phospho-IR/IGF1R pTyr1162/1163 recombinant rabbit monoclonal antibody (Product # 700393) at a dilution of 1ug/ml.
|Tested species reactivity||Human|
|Host / Isotype||Rabbit / IgG|
|Immunogen||A peptide corresponding to amino acids 1186-1197 and 1162-1173 of P06213 and P08069, respectively|
|Contains||0.09% sodium azide|
|Storage Conditions||Maintain refrigerated at 2-8°C for up to 1 month. For long term storage store at -20°C|
|Tested Applications||Dilution *|
|ELISA (ELISA)||1-5 ug/ml|
|Western Blot (WB)||1-2 ug/ml|
* Suggested working dilutions are given as a guide only. It is recommended that the user titrate the product for use in their own experiment using appropriate negative and positive controls.
This antibody is predicted to react with bovine, canine, chicken, chimpanzee, equine, mouse, rat, Rhesus monkey , porcine and Xenopus based on sequence homology.
ABfinity™ recombinant antibodies are rabbit monoclonal antibodies, unmatched for producing superior results. ABfinity™ antibodies are developed by immunizing animals, screening for functionality, cloning the immunogen-specific antibody genes into high-level mammalian expression vectors, produced on a large scale, and purified with Protein A.
ABfinity™ monoclonal antibodies resemble rabbit monoclonals isolated from serum or produced by hybridomas, but demonstrate greater specificity and sensitivity. Because ABfinity™ recombinant antibodies are derived from cloned DNA sequences of the heavy and light antibody chains, they are not susceptible to cell-line drift or lot-to-lot variation, thus allowing for peak specificity and performance.
Intact IgG appears on a non-reducing gel as ~150 kDa band and upon reduction generating a ~25 kDa light chain band and a ~50 kDa heavy chain.
Biological actions of insulin and IGF-1 are mediated by their respective cell surface receptor tyrosine kinases that regulate multiple signaling pathways through activation of a series of phosphorylation cascades. The insulin receptor. Insulin/IGF-1 binding to the extracellular domain leads to autophosphorylation of downstream target proteins. These two receptors differ in sequence in regions that confer specificity for the designated ligand as well as in certain intracellular signaling domains, resulting in significant differences in the functional consequences of activation of each receptor. Defects in IR are the cause of various insulin resistance syndromes and IGF-1R defects may cause some forms of growth retardation. Both these signaling cascades are also important for the development of cancer.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
CD220; CD221; HHF5; IGF-I Receptor; IGF1 Receptor; IGF1R; IGFIR; IGFR; INSR; Insulin receptor; Insulin-like growth factor 1 receptor; Insulin-like growth factor I receptor; IR; JTK13; soluble IGF1R variant 1; soluble IGF1R variant 2
CD220; CD221; HHF5; IGF1R; IGFIR; IGFR; INSR; JTK13